Pharmacokinetic and Pharmacodynamic Profile of New Biosimilar Filgrastim XM02 Equivalent to Marketed Filgrastim Neupogen®: Single-Blind, Randomized, Crossover Trial

Author: Lubenau Heinz  

Publisher: Adis International

ISSN: 1173-8804

Source: BioDrugs, Vol.23, Iss.1, 2009-01, pp. : 43-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content